BRAF and neoplasm: Our study identified FAK as a key regulator of BRAFV600E-induced ERK activation in mutant BRAF-induced serrated tumor formation/initiation and revealed that FAK loss allows BRAFV600E-induced ERK signaling to reach the permissive threshold “just-right” for cecal tumors to form.